What is the price-to-earnings ratio of Biosenic?
The price-earnings ratio of Biosenic is currently 0.
Biosenic P/S 2025
Biosenic P/S
0
Ticker
BIOS.BR
ISIN
BE0974280126
WKN
A14NHV
As of Feb 22, 2025, Biosenic's P/S ratio stood at 0, a 0% change from the 11.23 P/S ratio recorded in the previous year.
The Biosenic P/S history
Biosenic Aktienanalyse
What does Biosenic do?
Bone Therapeutics SA is a Belgian company specializing in the development of innovative therapies for bone and joint diseases. Its goal is to treat patients with severe orthopedic conditions and help improve their quality of life. The company's business model is based on extensive research and development strategies aimed at developing groundbreaking therapies for diseases such as fractures, osteoporosis, osteoarthritis, and other bone and joint-related conditions. It focuses on the development of innovative stem cell-based therapies that help repair damaged tissues and promote self-regeneration. Additionally, Bone Therapeutics has developed a special cell therapy called Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells, targeting cartilage growth as an alternative, cell-based therapy for knee and hip osteoarthritis. It has also developed a platform called Allogeneic Osteoblastic Cells, aiming to treat ligament and tendon injuries. The company conducts research and clinical studies in collaboration with academic partners to improve its therapies and develop new products and solutions. It operates in three business areas: Orthobiology, Cardiology, and Immunology, focusing on the development and marketing of therapies for bone and joint arthritis, cardiovascular diseases, and autoimmune diseases, respectively. Its current product offerings include Allob, AlgoScaff, and JTA-004 for the treatment of orthopedic conditions such as fractured vertebrae, severe bone injuries, bone regeneration, osteoporosis, and osteoarthritis. Bone Therapeutics is headquartered in Gosselies, Belgium, with offices in the US, France, Germany, and Italy. Its mission is to advance the development of therapies for bone and joint diseases and assist patients with severe orthopedic conditions. Through its research and development strategies, collaboration with academic partners, and strong market position, Bone Therapeutics aims to make a difference in the field. Biosenic ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Biosenic's P/S Ratio
Biosenic's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Biosenic's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Biosenic's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Biosenic’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Biosenic stock
How has the price-earnings ratio of Biosenic changed compared to last year?
The price-to-earnings ratio of Biosenic has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Biosenic high compared to other companies?
Yes, the price-to-earnings ratio of Biosenic is high compared to other companies.
How does an increase in the price-earnings ratio of Biosenic affect the company?
An increase in the price-earnings ratio of Biosenic would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Biosenic affect the company?
A decrease in the price-earnings ratio of Biosenic would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Biosenic?
Some factors that influence the price-earnings ratio of Biosenic are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Biosenic pay?
Over the past 12 months, Biosenic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biosenic is expected to pay a dividend of 0 EUR.
What is the dividend yield of Biosenic?
The current dividend yield of Biosenic is .
When does Biosenic pay dividends?
Biosenic pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Biosenic?
Biosenic paid dividends every year for the past 0 years.
What is the dividend of Biosenic?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Biosenic located?
Biosenic is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biosenic kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biosenic from 2/22/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 2/22/2025.
When did Biosenic pay the last dividend?
The last dividend was paid out on 2/22/2025.
What was the dividend of Biosenic in the year 2024?
In the year 2024, Biosenic distributed 0 EUR as dividends.
In which currency does Biosenic pay out the dividend?
The dividends of Biosenic are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Biosenic
Our stock analysis for Biosenic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biosenic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.